MHRA
The article provides an overview of the current reporting requirements for healthcare products allowed to be used for clinical trials.
AIaMD
The article provides a general overview of the new regulatory framework for innovative AI-based healthcare products intended to be marketed and used in the UK.
Great Britain
The new article outlines the list of questions raised by the regulating authority in the context of the initiated consultation and also provides definitions of the most important terms and concepts used.
Great Britain
The new article describes in detail the new regulatory policy for in vitro diagnostic medical devices as suggested by the UK authority.
Great Britain
The article highlights the key points associated with the concept of common specification requirements for certain products allowed to be marketed and used in the UK.
Great Britain
The new article describes in detail certain specific aspects associated with registrations necessary to make submissions associated with healthcare products.
